Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Description

The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.

Conditions

Opioid Withdrawal, Opioid Use Disorder

Study Overview

Study Details

Study overview

The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Condition
Opioid Withdrawal
Intervention / Treatment

-

Contacts and Locations

Center City

Hazelden Betty Ford Foundation, Center City, Minnesota, United States, 55012

Columbus

Battelle Memorial Institute, Columbus, Ohio, United States, 43201

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 50 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Spark Biomedical, Inc.,

    Navid Khodaparast, PhD, STUDY_CHAIR, Chief Science Officer

    Melanie McWade, PhD, STUDY_DIRECTOR, Senior Director of Clinical Operations

    Carlos Tirado, MD, STUDY_CHAIR, Medical Monitor

    Study Record Dates

    2025-07